Investors & Media Home

Download Mesoblast Corporate Backgrounder

Mesoblast Corporate Backgrounder (350 KB)

Mesoblast is a world leader in developing innovative cellular medicines.

The Company has established what it believes is the industry's most clinically advanced and diverse portfolio of cell-based product candidates ... More

Latest ASX AnnouncementsMore
14 January 2019
MSB Draws US$15 Million From Existing Facility
08 January 2019
MSB Highlights Key 2019 Priorities at U.S. Biotech Showcase
08 January 2019
Change of Director's Interest Notices
07 January 2019
P3 Trial of MSB's Cell Therapy in CHF Completes Recruitment
Upcoming EventsMore
There are currently no events scheduled.
Stock QuoteMore
Exchange :ASX
Price :A$1.37
Change : Stock is Up 0.07 (5.38%)
Volume :773,896
Data as of 18 January 2019 4:10 p.m. ET
Data provided by Nasdaq Minimum 15 minutes delay
Download Documentation First Quarter Results Presentation
Download Documentation 2018 Annual Report
Download Documentation Financial Results for the 2018 Full Financial Year, 4th Quarter Ended June 30, 2018
Download Documentation Financial Results for the Period Ended September 30, 2017
E-mail Alerts
Sign up to receive e-mail alerts.

Share Price ASX: MSB  AUD 1.37 as of Jan 18, 2019